The treatment of cancer with proton radiation therapy was first suggested in 1946 followed
by the first treatments in the 1950s. As of 2020, almost 200 000 patients have been treated …

Purpose Proton therapy can allow for superior avoidance of normal tissues. A widespread
consensus has been reached that proton therapy should be used for patients with curable …

Purpose To review current evidence of the role of proton therapy (PT) in other tumors than
skull base, sinusal/parasinusal, spinal and pediatric tumors; to determine medico-economic …

Owing to the limited availability of data on the outcome of proton therapy, treatments are
generally optimized based on broadly available data on photon-based treatments. However …

Conventional treatment options for clinically localized, low-risk prostate cancer include
radical prostatectomy, external-beam radiotherapy (EBRT) and low-dose-rate …

Proton therapy is very sensitive to daily density changes along the pencil beam paths. The
purpose of this study is to develop and evaluate an automated method for adaptation of …

BACKGROUND AND PURPOSE: Ongoing clinical trials aim to improve local control and
overall survival rates by intensification of therapy regimen for patients with locally advanced …

Internal target and organ motion during treatment is a challenge in radiotherapy (RT) of the
prostate and the involved elective targets, with residual motion being present also following …

Delivery time factor (DTF) is a new parameter introduced by the RayStation treatment
planning system for tomotherapy treatment planning. This study investigated the effects of …

Abstract The Danish Prostate Cancer Group is launching the randomized trial, PROstate
PROTON Trial 1 (NCT05350475), that compares photons and protons to the prostate and …